181 related articles for article (PubMed ID: 31663483)
1. Lipid and PLGA Microparticles for Sustained Delivery of Protein and Peptide Drugs.
Wu C; Mu H
Pharm Nanotechnol; 2020; 8(1):22-32. PubMed ID: 31663483
[TBL] [Abstract][Full Text] [Related]
2. In vivo evaluation of solid lipid microparticles and hybrid polymer-lipid microparticles for sustained delivery of leuprolide.
Wu C; Luo X; Baldursdottir SG; Yang M; Sun X; Mu H
Eur J Pharm Biopharm; 2019 Sep; 142():315-321. PubMed ID: 31299277
[TBL] [Abstract][Full Text] [Related]
3. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques.
Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W
Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795
[TBL] [Abstract][Full Text] [Related]
4. Comparative studies on exenatide-loaded poly (D,L-lactic-co-glycolic acid) microparticles prepared by a novel ultra-fine particle processing system and spray drying.
Zhu C; Huang Y; Zhang X; Mei L; Pan X; Li G; Wu C
Colloids Surf B Biointerfaces; 2015 Aug; 132():103-10. PubMed ID: 26037698
[TBL] [Abstract][Full Text] [Related]
5. PLGA, chitosan or chitosan-coated PLGA microparticles for alveolar delivery? A comparative study of particle stability during nebulization.
Manca ML; Mourtas S; Dracopoulos V; Fadda AM; Antimisiaris SG
Colloids Surf B Biointerfaces; 2008 Apr; 62(2):220-31. PubMed ID: 18023977
[TBL] [Abstract][Full Text] [Related]
6. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
Witschi C; Doelker E
J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in the preparation progress of protein/peptide drug loaded PLA/PLGA microspheres.
Xu FH; Zhang Q
Yao Xue Xue Bao; 2007 Jan; 42(1):1-7. PubMed ID: 17520799
[TBL] [Abstract][Full Text] [Related]
8. Bioactive Hybrid Particles from Poly(D,L-lactide-co-glycolide) Nanoparticle Stabilized Lipid Droplets.
Joyce P; Whitby CP; Prestidge CA
ACS Appl Mater Interfaces; 2015 Aug; 7(31):17460-70. PubMed ID: 26181279
[TBL] [Abstract][Full Text] [Related]
9. Effect of excipients on encapsulation and release of insulin from spray-dried solid lipid microparticles.
Wu C; van de Weert M; Baldursdottir SG; Yang M; Mu H
Int J Pharm; 2018 Oct; 550(1-2):439-446. PubMed ID: 30196139
[TBL] [Abstract][Full Text] [Related]
10. Albumin-coated porous hollow poly(lactic-co-glycolic acid) microparticles bound with palmityl-acylated exendin-4 as a long-acting inhalation delivery system for the treatment of diabetes.
Kim H; Lee J; Kim TH; Lee ES; Oh KT; Lee DH; Park ES; Bae YH; Lee KC; Youn YS
Pharm Res; 2011 Aug; 28(8):2008-19. PubMed ID: 21472489
[TBL] [Abstract][Full Text] [Related]
11. Formation Mechanism, In vitro and In vivo Evaluation of Dimpled Exenatide Loaded PLGA Microparticles Prepared by Ultra-Fine Particle Processing System.
Zhu C; Peng T; Huang D; Feng D; Wang X; Pan X; Tan W; Wu C
AAPS PharmSciTech; 2019 Jan; 20(2):64. PubMed ID: 30627822
[TBL] [Abstract][Full Text] [Related]
12. Sustained intravitreal delivery of connexin43 mimetic peptide by poly(D,L-lactide-co-glycolide) acid micro- and nanoparticles--Closing the gap in retinal ischaemia.
Chen YS; Green CR; Wang K; Danesh-Meyer HV; Rupenthal ID
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):378-86. PubMed ID: 25497487
[TBL] [Abstract][Full Text] [Related]
13. Preparation of uniform-sized exenatide-loaded PLGA microspheres as long-effective release system with high encapsulation efficiency and bio-stability.
Qi F; Wu J; Fan Q; He F; Tian G; Yang T; Ma G; Su Z
Colloids Surf B Biointerfaces; 2013 Dec; 112():492-8. PubMed ID: 24075786
[TBL] [Abstract][Full Text] [Related]
14. Release of rifampicin from chitosan, PLGA and chitosan-coated PLGA microparticles.
Manca ML; Loy G; Zaru M; Fadda AM; Antimisiaris SG
Colloids Surf B Biointerfaces; 2008 Dec; 67(2):166-70. PubMed ID: 18835764
[TBL] [Abstract][Full Text] [Related]
15. Surface-functionalized, pH-responsive poly(lactic-co-glycolic acid)-based microparticles for intranasal vaccine delivery: Effect of surface modification with chitosan and mannan.
Li Z; Xiong F; He J; Dai X; Wang G
Eur J Pharm Biopharm; 2016 Dec; 109():24-34. PubMed ID: 27569030
[TBL] [Abstract][Full Text] [Related]
16. Development of highly porous large PLGA microparticles for pulmonary drug delivery.
Yang Y; Bajaj N; Xu P; Ohn K; Tsifansky MD; Yeo Y
Biomaterials; 2009 Apr; 30(10):1947-53. PubMed ID: 19135245
[TBL] [Abstract][Full Text] [Related]
17. Water-soluble betamethasone-loaded poly(lactide-co-glycolide) hollow microparticles as a sustained release dosage form.
Chaw CS; Yang YY; Lim IJ; Phan TT
J Microencapsul; 2003; 20(3):349-59. PubMed ID: 12881115
[TBL] [Abstract][Full Text] [Related]
18. Biodegradation and heart retention of polymeric microparticles in a rat model of myocardial ischemia.
Formiga FR; Garbayo E; Díaz-Herráez P; Abizanda G; Simón-Yarza T; Tamayo E; Prósper F; Blanco-Prieto MJ
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):665-72. PubMed ID: 23523545
[TBL] [Abstract][Full Text] [Related]
19. Rationalized design to explore the full potential of PLGA microspheres as drug delivery systems.
Martinez-Borrajo R; Diaz-Rodriguez P; Landin M
Drug Deliv; 2023 Dec; 30(1):2219864. PubMed ID: 37272488
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of poly (lactic-co-glycolic acid)-poly ethyleneimine-plasmid DNA microparticles prepared using double emulsion methods.
Zhang XQ; Intra J; Salem AK
J Microencapsul; 2008 Feb; 25(1):1-12. PubMed ID: 18188727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
